SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Street Walker who started this subject11/7/2000 12:08:01 PM
From: Bo Didley  Read Replies (1) of 5582
 
I visit Silicon once in great while.

In the past, this board use to have only a few
posts a month. Easy reading. Now I come here and
in the last week there has been so much useless information
posted its not even worth reading all the trash talk of
the shorts. All anyone has to do is read the last few news releases and that say whats going on with the company.

I do see where Anthony declared GUMM a short yesterday at $11 1/4.
I'll be reviewing his investment over the next year
and remind him (and others) of his track record on GUMM.
There's a saying, "Shorts yell loudest at the bottom".

Some of you are high profile shorters and attract funds
who specialize in creating short squeezes. All the shorts here remain short at $11 1/4. Okay, lets watch and see how they do on their short over the next year. Personally,
I don't think these shorts have the staying power to remain short. They have a history of moving on to other stocks, but before they do, they will be future buyers at higher prices than $11 1/4.

I talk to local pharmacists and they say Zicam is selling extremely well and that will be reflected in Q4 results.

bo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext